Market overview
The global organ preservation & perfusion products market is worth USD 1.4 bn in 2026 and is forecast to reach USD 4.0 bn by 2036, growing at a 11.0% CAGR. United States is the largest country market and Normothermic machine perfusion is the largest by product segment.
| Scope | Solutions, static cold-storage and transport devices, and hypothermic and normothermic machine perfusion systems and disposables used to preserve donor hearts, lungs, livers and kidneys between retrieval and transplant. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 1.2 bn |
| Value 2026 | USD 1.4 bn |
| Value 2036 | USD 4.0 bn |
| CAGR 2026-2036 | 11.0% |
| Volume 2026 | 169,307 units |
| Volume 2036 | 435,202 units |
| Average price 2026 | USD 8,417 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Organ Preservation & Perfusion Products market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 1.4 bn |
| 2027 | USD 1.6 bn |
| 2028 | USD 1.8 bn |
| 2029 | USD 1.9 bn |
| 2030 | USD 2.2 bn |
| 2031 | USD 2.4 bn |
| 2032 | USD 2.7 bn |
| 2033 | USD 3.0 bn |
| 2034 | USD 3.3 bn |
| 2035 | USD 3.6 bn |
| 2036 | USD 4.0 bn |
Organ Preservation & Perfusion Products market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Preservation solutions | 24.0% | 15.2% | USD 342 mn | 6.0% |
| Static cold-storage and transport devices | 20.0% | 16.0% | USD 285 mn | 8.6% |
| Hypothermic machine perfusion | 20.0% | 19.2% | USD 285 mn | 10.6% |
| Normothermic machine perfusion | 36.0% | 49.5% | USD 513 mn | 14.6% |
By organ
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Kidney | 30.0% | 24.2% | USD 428 mn | 8.7% |
| Liver | 28.0% | 32.6% | USD 399 mn | 12.7% |
| Heart | 22.0% | 25.6% | USD 314 mn | 12.7% |
| Lung | 14.0% | 13.6% | USD 200 mn | 10.7% |
| Other | 6.0% | 4.0% | USD 86 mn | 6.7% |
By preservation method
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Static cold storage | 46.0% | 36.0% | USD 656 mn | 8.3% |
| Hypothermic machine perfusion | 26.0% | 30.0% | USD 370 mn | 12.6% |
| Normothermic machine perfusion | 20.0% | 26.0% | USD 285 mn | 13.9% |
| Cryopreservation | 8.0% | 8.0% | USD 114 mn | 11.0% |
By component
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Perfusion devices | 36.0% | 36.0% | USD 513 mn | 11.0% |
| Preservation solutions | 34.0% | 31.0% | USD 484 mn | 10.0% |
| Disposables and accessories | 30.0% | 33.0% | USD 428 mn | 12.1% |
By donor type
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Brain-dead donors | 56.0% | 50.0% | USD 798 mn | 9.8% |
| Donation after circulatory death | 34.0% | 38.0% | USD 484 mn | 12.2% |
| Living donors | 10.0% | 12.0% | USD 142 mn | 13.0% |
Top 25 countries for organ preservation & perfusion products by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 88.0% of 2026 revenue and the 25 countries below together hold 96.4%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 826 mn | 58.0% | USD 2.4 bn | 11.2% |
| 2 | Germany | USD 71 mn | 5.0% | USD 190 mn | 10.3% |
| 3 | United Kingdom | USD 71 mn | 5.0% | USD 190 mn | 10.3% |
| 4 | France | USD 57 mn | 4.0% | USD 138 mn | 9.2% |
| 5 | Italy | USD 43 mn | 3.0% | USD 105 mn | 9.4% |
| 6 | Spain | USD 43 mn | 3.0% | USD 105 mn | 9.4% |
| 7 | Canada | USD 43 mn | 3.0% | USD 113 mn | 10.2% |
| 8 | China | USD 43 mn | 3.0% | USD 178 mn | 15.3% |
| 9 | Japan | USD 28 mn | 2.0% | USD 65 mn | 8.6% |
| 10 | Australia | USD 28 mn | 2.0% | USD 77 mn | 10.4% |
| 11 | Netherlands | USD 18 mn | 1.3% | USD 53 mn | 11.3% |
| 12 | Belgium | USD 15 mn | 1.1% | USD 44 mn | 11.3% |
| 13 | Switzerland | USD 14 mn | 1.0% | USD 41 mn | 11.3% |
| 14 | Sweden | USD 13 mn | 0.9% | USD 36 mn | 11.2% |
| 15 | Austria | USD 10.0 mn | 0.7% | USD 29 mn | 11.3% |
| 16 | Denmark | USD 9.0 mn | 0.6% | USD 26 mn | 11.2% |
| 17 | Norway | USD 8.0 mn | 0.6% | USD 23 mn | 11.2% |
| 18 | South Korea | USD 6.8 mn | 0.5% | USD 20 mn | 11.2% |
| 19 | Brazil | USD 5.4 mn | 0.4% | USD 16 mn | 11.3% |
| 20 | Mexico | USD 4.8 mn | 0.3% | USD 14 mn | 11.3% |
| 21 | India | USD 4.4 mn | 0.3% | USD 13 mn | 11.0% |
| 22 | Poland | USD 3.7 mn | 0.3% | USD 11 mn | 11.4% |
| 23 | Israel | USD 3.0 mn | 0.2% | USD 8.5 mn | 11.0% |
| 24 | Argentina | USD 2.4 mn | 0.2% | USD 7.3 mn | 11.6% |
| 25 | Singapore | USD 2.3 mn | 0.2% | USD 6.5 mn | 11.0% |
| Rest of world | USD 51 mn | 3.6% | USD 138 mn | 10.4% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- TransMedics
- XVIVO Perfusion
- Getinge
- Terumo
Group 2: Regional and specialist players
- Bridge to Life
- Organ Recovery Systems
- Essential Pharma
- Paragonix Technologies
- Institut Georges Lopez
- Lung Bioengineering
Group 3: Emerging and niche players
- Waters Medical Systems
- Organ Assist
- Hemarina
- Aferetica
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the organ preservation & perfusion products market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 11.0% is calculated from the resulting values.
The market is divided by product, by organ, by preservation method, by component, by donor type. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the organ preservation & perfusion products market?
The global organ preservation & perfusion products market is estimated at USD 1.2 bn in 2025 and USD 1.4 bn in 2026.
How fast will the organ preservation & perfusion products market grow?
It is forecast to reach USD 4.0 bn by 2036, a compound annual growth rate of 11.0% from 2026, an increase of USD 2.6 bn.
Which country is the largest market for organ preservation & perfusion products?
United States is the largest market by revenue at USD 826 mn in 2026, 58.0% of the global total. The three largest countries together hold 68.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 15.3% a year from 2026 to 2036.
Which organ preservation & perfusion products segment is largest?
In the by product split, Normothermic machine perfusion is the largest segment with 36.0% of 2026 revenue.
Who are the leading organ preservation & perfusion products companies?
Global leaders include TransMedics, XVIVO Perfusion, Getinge, Terumo.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Blister MachineUSD 1.4 bn · 5.5% CAGR
- Muscle Stimulation DevicesUSD 1.4 bn · 5.8% CAGR
- Neurosurgery & Spine RobotsUSD 1.4 bn · 12.0% CAGR
- 3D Imaging Surgical SolutionUSD 1.5 bn · 8.5% CAGR
- Eosinophilic EsophagitisUSD 1.4 bn · 12.0% CAGR
- IsolatorUSD 1.5 bn · 8.2% CAGR
- Urethral Balloon CathetersUSD 1.4 bn · 4.3% CAGR
- Vascular Thromboembolic Disease ThrombectomyUSD 1.5 bn · 13.0% CAGR